Anti-dementia medication use in Aotearoa New Zealand: An exploratory study using health data from the Integrated Data Infrastructure (IDI).
Amy Hai Yan ChanJo Anna HikakaEdith ToSarah CullumEtuini Ma'uBrigid RyanClaudia Rivera-RodriguezGary CheungPublished in: The Australian and New Zealand journal of psychiatry (2022)
This study provides important information about funded anti-dementia medication use in New Zealand and how this differs by ethnicity, age and sex. Despite higher dementia prevalence in Māori and Pacific peoples, these groups were less likely to receive funded anti-dementia medication.